Skip to Main Content

Author Details

Xin Yang
Peking University Cancer Hospital & Institute
2002
64
17
PMIDPaper TitleJournal TitlePublished Year
36759599The phosphorylation of PHF5A by TrkA-ERK1/2-ABL1 cascade regulates centrosome separation.Cell Death Dis2023
38067352Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and "the So-Called Reported Histologic Transformation".Cancers (Basel)2023
37742943Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.Hum Pathol2023
37723144Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression.Cell Discov2023
36842439Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.Lancet2023
34753887Among Multiple Needle Core Biopsy Samples, the One with the Highest Tumor Proportion Score Best Represents the PD-L1 Status of the Whole Surgical Specimen in Non-Small Cell Lung Cancer.Appl Immunohistochem Mol Morphol2022
35732801Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage.Oncogene2022
35668195Primary malignant melanoma of the esophagus: differentiation from esophageal squamous cell carcinoma and leiomyoma using dynamic contrast-enhanced CT findings.Abdom Radiol (NY)2022
35530284Endoscopic features of esophageal high-grade intraepithelial neoplasia dominated by cytological atypia.Am J Cancer Res2022
35662334Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.J Gene Med2022
35595220Marsdenia tenacissima (Roxb.) Moon injection exerts a potential anti-tumor effect in prostate cancer through inhibiting ErbB2-GSK3β-HIF1α signaling axis.J Ethnopharmacol2022
36420535Dynamic regulation of eEF1A1 acetylation affects colorectal carcinogenesis.Biol Chem2022
36247875Comprehensive Analysis of the Role of <i>SLC2A3</i> on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.Anal Cell Pathol (Amst)2022
33782193Validation of multiplex immunofluorescence and digital image analysis for programmed death-ligand 1 expression and immune cell assessment in non-small cell lung cancer: comparison with conventional immunohistochemistry.J Clin Pathol2022
35246953A prognostic classification based on the International Association for the Study of Lung Cancer histologic grading and immunoscore in KRAS-mutant invasive non-mucinous adenocarcinoma.Thorac Cancer2022
35211858Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma.Ann Surg Oncol2022
34493824Heterogeneity of programmed death-ligand 1 expression and infiltrating lymphocytes in paired resected primary and metastatic non-small cell lung cancer.Mod Pathol2022
34406172Effectiveness of Vitamin C Solution in Reducing Adverse Reactions Caused by Painless Lugol Chromoendoscopy: A Multicenter Randomized Controlled Trial.J Clin Gastroenterol2022
34518630Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer.Mod Pathol2022
34253867Major pathologic response assessment and clinical significance of metastatic lymph nodes after neoadjuvant therapy for non-small cell lung cancer.Mod Pathol2021
33825946Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.Virchows Arch2021
33508502Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts.Mol Cell Proteomics2021
35003359PD-L1 Expression in Chinese Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Multi-Center Retrospective Observational Study.J Cancer2021
34367963RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.Front Oncol2021
32141187SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases.EMBO Rep2020
35117517The prognostic analysis of lung cancer patients with occult malignant pleural disease at thoracotomy.Transl Cancer Res2020
32604042Deep learning combined with radiomics may optimize the prediction in differentiating high-grade lung adenocarcinomas in ground glass opacity lesions on CT scans.Eur J Radiol2020
32703935Deacetylation of HSD17B10 by SIRT3 regulates cell growth and cell resistance under oxidative and starvation stresses.Cell Death Dis2020
32641353WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.Diabetes2020
32284438Citrate synthase desuccinylation by SIRT5 promotes colon cancer cell proliferation and migration.Biol Chem2020
30532073MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner.Oncogene2019
31933822miR-516a-3p promotes proliferation, migration, and invasion and inhibits apoptosis in lung adenocarcinoma by targeting PTPRD.Int J Clin Exp Pathol2019
31661545Abnormally localized DLK1 interacts with NCOR1 in non-small cell lung cancer cell nuclear.Biosci Rep2019
31291454ULK1 phosphorylates Mad1 to regulate spindle assembly checkpoint.Nucleic Acids Res2019
30807354Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors.Chin Med J (Engl)2019
30799956Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study.Cancer Manag Res2019
31115014KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.Eur Rev Med Pharmacol Sci2019
30885334A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy.Lung Cancer2019
31054974Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.Mol Cell2019
31108370SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.Neoplasia2019
30649986SIRT4 regulates PTEN stability through IDE in response to cellular stresses.FASEB J2019
29180469SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.Cancer Res2018
29995581Autophagy-deficient tumor cells rely on extracellular amino acids to survive upon glutamine deprivation.Autophagy2018
29874586Increased Amino Acid Uptake Supports Autophagy-Deficient Cell Survival upon Glutamine Deprivation.Cell Rep2018
30034937MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.Am J Cancer Res2018
30420048Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.Hum Pathol2018
29789013Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.Diagn Pathol2018
27426975Primary Tumor Location Is a Useful Predictor for Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma.Clin Lung Cancer2017
28342951A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.Clin Gastroenterol Hepatol2017
28981103A novel acridine derivative, LS-1-10 inhibits autophagic degradation and triggers apoptosis in colon cancer cells.Cell Death Dis2017
  • 1 - 50 of 64

Recommended Authors

Zisheng Chen
The Sixth Affiliated Hospital of Guangzhou Medical University
Career Start Year 2018
Number of shared co-authors 1
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Wei Wang
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Hao Tang
Guizhou Medical University
Career Start Year 2013
Number of shared co-authors 0
Shuhua Li
The First Affiliated Hospital, Sun Yat-sen University
Career Start Year 2012
Number of shared co-authors 0
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 1
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 1
Jun Huang
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2006
Number of shared co-authors 1
Li Liu
Central South University
Career Start Year 2006
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 1
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Haitao Lan
Academy of Medical Sciences, Sichuan Provincial People's Hospital
Career Start Year 2003
Number of shared co-authors 0
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 3
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 2
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Career Start Year 1998
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 0
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 2

Collaborators

Yue Yang
Peking University Cancer Hospital
Co-authored papers 5
Shaolei Li
Peking University Cancer Hospital & Institute
Co-authored papers 5
Shi Yan
Qilu Hospital of Shandong University
Co-authored papers 5
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Co-authored papers 5
Miao Yu
Co-authored papers 5
Liyan Xue
Xuzhou Central Hospital
Co-authored papers 2
Xing Wang
Shanghai Children's Hospital, Shanghai Jiao Tong University
Co-authored papers 1
Quanzheng Li
Massachusetts General Hospital
Co-authored papers 1
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Co-authored papers 1
Lei Tang
Peking University Cancer Hospital and Institute
Co-authored papers 1
Jie Zhao
Center for Data Science in Health and Medicine, Peking University
Co-authored papers 1
Gaoxiang Chen
Center for Data Science, Peking University
Co-authored papers 1
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 1
Yue Kang
Co-authored papers 1
Li Zhang
Chang'an University
Co-authored papers 1
Xiang Li
Peking University Cancer Hospital & Institute
Co-authored papers 1
Release 1.2